Evidence map›Paper›PMID 40641633›Full record

ReviewEndocrine oncology (Bristol, England)2025

SIADH as an uncommon presentation of olfactory neuroblastoma: a case-based overview.

Solene Papart, Adrian F Daly, Elettra Bianchi, Alexandre Jadoul, Gilles Reuter, Olivier Bouchain, Patrick Pétrossians, Albert Beckers

Abstract readReview
In one paragraph

Review in Endocrine oncology (Bristol, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Solene PapartDepartment of Opthalmology, Centre Hospitalier Universitaire de Liège, University of Liège, Liège, Belgium.
Adrian F DalyDepartment of Endocrinology, Centre Hospitalier Universitaire de Liège, University of Liège, Liège, Belgium.ORCID https://orcid.org/0000-0001-6130-2975
Elettra BianchiDepartment of Pathology, Centre Hospitalier Universitaire de Liège, University of Liège, Liège, Belgium.
Alexandre JadoulDepartment of Nuclear Medicine, Centre Hospitalier Universitaire de Liège, University of Liège, Liège, Belgium.
Gilles ReuterDepartment of Neurosurgery, Centre Hospitalier Universitaire de Liège, University of Liège, Liège, Belgium.
Olivier BouchainDepartment of Otorhinolaryngology, Centre Hospitalier Universitaire de Liège, University of Liège, Liège, Belgium.
Patrick PétrossiansDepartment of Endocrinology, Centre Hospitalier Universitaire de Liège, University of Liège, Liège, Belgium.ORCID https://orcid.org/0000-0003-0271-136X
Albert BeckersDepartment of Endocrinology, Centre Hospitalier Universitaire de Liège, University of Liège, Liège, Belgium.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Olfactory neuroblastoma (ONB) is a rare malignant neuroectodermal tumour that usually arises in the nasal cavity, typically presenting with unilateral nasal obstruction and epistaxis. In rare instances, ONB can manifest as a paraneoplastic syndrome of inappropriate antidiuretic hormone (SIADH) secretion, leading to hyponatraemia. Case presentation: We describe a 42-year-old woman with a 4-year history of cyclical, symptomatic hyponatraemia characterised by intermittent episodes of dizziness, severe headaches and marked fatigue, initially without overt nasal or otolaryngological symptoms. Investigations confirmed SIADH, yet repeated imaging (including thoracic CT and FDG PET-CT) failed to identify a source. Eventually, a Literature review: ONB accounts for <3% of nasal tumours and can present with non-specific symptoms, delaying diagnosis. Most patients have a typical combination of nasal obstruction and epistaxis, but paraneoplastic SIADH is reported in about 2% of cases. Complete surgical excision is the cornerstone of therapy, often accompanied by radiotherapy or chemotherapy for higher-grade lesions. Recent advances suggest that somatostatin receptor imaging and targeted radionuclide therapy might benefit select patients, particularly those with unresectable or recurrent disease. Conclusion: This case highlights the importance of considering ONB in patients with unexplained SIADH, especially when initial investigations are inconclusive. It also underscores the utility of

Indexed as

esthesioneuroblastomahyponatraemiaolfactory neuroblastomaparaneoplasticSIADH

Identifiers

PMID40641633
PMCPMC12242914

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.